Events & Presentations

Date	Event Details	Remind Me
May 4, 2021 4:30 PM EDT	Arrowhead Pharmaceuticals 2021 Second Quarter Results Listen to webcast	Add to Outlook Add to Google Calendar

Date	Event Details
Sep 30 - Oct 3, 2018	The 14th Annual Meeting of the Oligonucleotide Therapeutics Society Supporting Materials: OTS 2018 ARO-HIF2 5.1 MB OTS 2018 ARO-ANG3 898.4 KB OTS 2018 HBV and AAT 7.1 MB Location: Seattle, WA View Additional Information October 1, 9:20 a.m. PDT – Zhen Li, Ph.D., Arrowhead’s senior vice president of chemistry and non-clinical development, will deliver an oral presentation titled, “Direct conjugation approaches in RNAi come of age – Successful delivery outside of hepatocytes” October 1, 5:00 p.m. PDT – Rui Zhu, Ph.D., Arrowhead’s senior process chemist, will deliver a poster presentation titled, “Subcutaneous delivery of an effective RNA interference (RNAi) therapeutic candidate silencing angiopoietin-like protein 3 for treatment of hyperlipidemia” October 3,4:00 p.m. PDT – James Hamilton M.D., MBA,Arrowhead’s vice president of clinical development, will deliver an invited, late-breaker oral presentation titled, “Clinical Development of RNAi Therapeutics for HBV and Alpha-1 Antitrypsin Deficiency”
Sep 25, 2018 12:00 PM EDT	Antivirals: Targeting HBV and Beyond Supporting Materials: View Presentation 9.9 MB View Additional Information James Hamilton, M.D., Arrowhead’s vice president of clinical development, will deliver an oral presentation titled, “Using siRNA to target the HBV transcriptome”
Sep 16, 2018 12:15 PM CDT	European Respiratory Society International Congress 2018 Supporting Materials: View Presentation 1.2 MB View Additional Information September 16, 12:15 p.m. CEST – Erik Bush, Ph.D., Arrowhead’s director of extra-hepatic targeting, will deliver an oral presentation titled, Targeting ENaC with an epithelial RNAi trigger delivery platform for the treatment of cystic fibrosis”
Sep 7, 2018 5:45 PM EDT	18th World Gastroenterologists Summit Supporting Materials: View Presentation 16.1 MB View Additional Information September 7, 09:45 a.m. NZST – Dr. Given will deliver a keynote presentation titled, “Hepatitis B in focus: New biology, new targets and real hope for finite therapy”
Sep 4, 2018	Annual B. Riley FBR Healthcare Conference View Additional Information Bruce Given, M.D., Arrowhead’s chief operating officer, and Vincent Anzalone, CFA, vice president of investor relations, will participate in three panel discussions
Aug 7, 2018 4:30 PM EDT	Arrowhead Fiscal 2018 Third Quarter Results Listen to webcast Supporting Materials: View Transcript 137 KB
Jun 29, 2018 3:45 PM PDT	27th Annual Alpha-1 National Education Conference Supporting Materials: View Presentation 9.7 MB Location: San Francisco, CA View Additional Information Bruce Given, M.D., will deliver an oral presentation titled, “Development of ARO-AAT, an RNAi based therapeutic for Alpha-1 antitrypsin deficiency-related liver disease”
Jun 20, 2018 9:00 AM EDT	JMP Securities Life Science Conference Listen to webcast Supporting Materials: View Presentation 16.1 MB Location: New York, NY View Additional Information Bruce Given, M.D., will present a corporate overview
Jun 15, 2018 2:15 PM EDT	Global Hepatitis Summit 2018 Supporting Materials: View Presentation 1.5 MB Location: Toronto View Additional Information Christine Wooddell, Ph.D., Arrowhead’s director of liver targeting, will deliver an oral presentation titled, “Interferon-gamma pathway is activated in a chronically HBV infected chimpanzee that controls HBV following ARC-520 RNAi treatment”
Jun 8, 2018 5:30 PM +08	The Science of HBV Cure 2018 Supporting Materials: View Presentation 6 MB Location: Suntec City, Singapore View Additional Information Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, will deliver an oral presentation titled, “Hitting HBV everywhere; why RNAi holds so much potential as a platform therapy in CHB”